Indan Journal of Medical Research Indan Journal of Medical Research Indan Journal of Medical Research Indan Journal of Medical Research
  Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login  
  Home Print this page Email this page Small font sizeDefault font sizeIncrease font size Users Online: 734       

   Table of Contents      
BOOK REVIEW
Year : 2017  |  Volume : 145  |  Issue : 4  |  Page : 577

Anti-tumor necrosis factor therapy in inflammatory bowel disease


Institute of Gastroenterology, SRM Institutes of Medical Science Hospital, Chennai 600 026, Tamil Nadu, India

Date of Web Publication28-Aug-2017

Correspondence Address:
B S Ramakrishna
Institute of Gastroenterology, SRM Institutes of Medical Science Hospital, Chennai 600 026, Tamil Nadu
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0971-5916.213765

Rights and Permissions

How to cite this article:
Ramakrishna B S. Anti-tumor necrosis factor therapy in inflammatory bowel disease. Indian J Med Res 2017;145:577

How to cite this URL:
Ramakrishna B S. Anti-tumor necrosis factor therapy in inflammatory bowel disease. Indian J Med Res [serial online] 2017 [cited 2019 Nov 19];145:577. Available from: http://www.ijmr.org.in/text.asp?2017/145/4/577/213765



G. Rogler, H. Herfarth, T. Hibi, O.H. Nielsen, editors (Karger, Basel, Switzerland) 2015. 240 pages. Price: US$ 233.00/CHF 198.00/EUR 185.00

ISBN 978-3-318-05473-6

This book is the 34th volume of the ongoing series 'Frontiers of Gastrointestinal Research. It has 35 chapters dealing exclusively with anti-tumour necrosis factor (TNF) therapy in inflammatory bowel disease (IBD). The initial sections of the book comprehensively review the role of TNF in the pathogenesis of IBD, including its regulatory effect on epithelial function, macrophage and dendritic cell function, T cell function, barrier function, innate immune defense mechanisms, and adaptive immune mechanisms. This is followed by chapters that review how anti-TNF antibodies act to bind membrane bound TNF, to neutralize soluble TNF, and to regulate T cells and monocytes. The remaining two thirds of the book is of significant interest to clinicians and IBD physicians. The latter section is also comprehensive, dealing with screening prior to therapy, the problem of neutralizing antibodies and how this impacts treatment, and the role of measuring anti-TNF trough concentrations. Side effects of these agents on the skin, vascular sites and a lupus-like syndrome, are all covered in detail. The risks of longer term therapy including infections and haematologic malignancies are also discussed in detail. The use of anti-TNF therapies in specific diseases including Crohn's disease and ulcerative colitis, and their use in sub-groups of IBD, during breast feeding and prior to surgery are also discussed in detail. It is disappointing that there is no separate chapter available dealing with the specific antibodies, though the information is spread throughout the book. There is a small section on biosimilars which could have been more elaborate and discussed the biosimilars available in the market and the experience with these. Biosimilars are likely to make a high impact in years to come and an in depth discussion would have been appropriate.

Overall, this book seeks to be a comprehensive reference on this rather limited subject. It will be of use to all IBD researchers and physicians and is well worth a place in their libraries.






 

Top
 
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article

 Article Access Statistics
    Viewed229    
    Printed3    
    Emailed0    
    PDF Downloaded103    
    Comments [Add]    

Recommend this journal